SACHIN GAURAV, II, PhD

NIH-NIAID
Frederick, MD, United States

Working in the field of clinical immunology

Disclosure information not submitted.

Presentation(s):

• 0038: STING Antagonist (IFM4490) Inhibits STING Activation and STING Dependent Signal Transduction in Patients with STING-associated Vasculopathy with Onset in Infancy (SAVI)

  Saturday, November 12, 2022
  1:00 PM – 1:05 PM Eastern Time

• 0038: STING Antagonist (IFM4490) Inhibits STING Activation and STING Dependent Signal Transduction in Patients with STING-associated Vasculopathy with Onset in Infancy (SAVI)

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time